Develops a 'human in silico model' that integrates multiomic big data and quantum chemistry for AI drug discovery.
| Date | Round | Amount |
|---|---|---|
| Sep 2025 | Series A Tres Alchemix raised 650 million yen in a Series A led by DNX Ventures with Waseda University Ventures, opening a laboratory in Oxford. | $4.2M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.